Chief Investment Strategist
Summary: Post the US election technology and health care stocks have been rallying as a Biden victory and senate majority by the Republicans removes the policy uncertainty on corporate tax rate and health care reforms including revising drug prices. We are also observing a collapse in the spot VIX Index and a general downward shift of the entire VIX futures curve indicating that investors are removing tail-risk hedges post the US election changing the narrative back to 'there is no alternative' bidding up equities across the board. The lack of 'Blue Wave' has also punctuated the reflation trade for now sending bond yields lower. Overall, the optimal mix of reactions for the equity market and especially growth stocks.
Global equities are galloping higher post the US election with US technology stocks leading the gains with Nasdaq 100 futures up almost 3% in today’s session extending on yesterday’s momentum. It looks increasingly clear that Biden will win the US election and with high enough margin that a real ugly contested post-election period is out of the question. The senate will most likely not swing into Democratic majority as a result we have very much status quo in terms of the pre-election risk of ‘Blue Wave’ which could have led to corporate tax rate hikes (especially the GILTI tax rate on income from intangibles) and a health care reform. This scenario is getting priced out and as a result health care and technology stocks are gaining relative to other segments. For the energy sector the election outcome is neutral for both the oil & gas and green energy industries. With a Biden victory it seems emerging markets are pricing in a slightly different foreign policy which could lift valuations of Chinese equities
Another important development after the US election has been the collapse in the VIX Index which has gone from 37 the day before the election to 26 as of today. The entire VIX futures forward curve has moved down in what is most likely tail-risk hedges being removed in the market and that the greatest uncertainty around the election has been removed. Due to the enormous one-way trades in weekly and monthly single stock options by retail investors we do not think that we will go back to the pre-commission free days where the VIX curve was in steep contango with the VIX spot anchored at a very low level. It will be a different volatility market going forward.
With a republican senate control we will most likely not get the big bazooka on fiscal impulse and as such the reflation trade is losing a bit momentum. As a result, government bond yields will stay subdued for some time and that is clearly resuming the TINA (‘there’s no alternative’) trade with the long duration assets (growth stocks, real estate etc.) being bid up in price. The Nasdaq 100 Index still represent the fastest growing companies with strong free cash flow generation and our calculations show that the free cash flow yield on Nasdaq 100 is still around 2% above the global corporate bond index yield-to-worst indicating an aggressive premium on growth stocks but not something to fear. The growth stocks segment also provides compounding on revenue in the case inflation comes after all, so our view is still that investors should have an overweight position in growth stocks.
The chart below is for regulatory purposes.
Quarterly Outlook
Chief Investment Strategist
Quarterly Outlook
Head of Fixed Income Strategy
Quarterly Outlook
Chief Investment Strategist
Quarterly Outlook
Chief Investment Strategist
Quarterly Outlook
Head of Commodity Strategy
Quarterly Outlook
Chief Investment Strategist
Quarterly Outlook
Chief Investment Strategist
Quarterly Outlook
Chief Investment Strategist
Quarterly Outlook
Head of Fixed Income Strategy
Quarterly Outlook
Head of Commodity Strategy
Disclaimer
The Saxo Bank Group entities each provide execution-only service and access to Analysis permitting a person to view and/or use content available on or via the website. This content is not intended to and does not change or expand on the execution-only service. Such access and use are at all times subject to (i) The Terms of Use; (ii) Full Disclaimer; (iii) The Risk Warning; (iv) the Rules of Engagement and (v) Notices applying to Saxo News & Research and/or its content in addition (where relevant) to the terms governing the use of hyperlinks on the website of a member of the Saxo Bank Group by which access to Saxo News & Research is gained. Such content is therefore provided as no more than information. In particular no advice is intended to be provided or to be relied on as provided nor endorsed by any Saxo Bank Group entity; nor is it to be construed as solicitation or an incentive provided to subscribe for or sell or purchase any financial instrument. All trading or investments you make must be pursuant to your own unprompted and informed self-directed decision. As such no Saxo Bank Group entity will have or be liable for any losses that you may sustain as a result of any investment decision made in reliance on information which is available on Saxo News & Research or as a result of the use of the Saxo News & Research. Orders given and trades effected are deemed intended to be given or effected for the account of the customer with the Saxo Bank Group entity operating in the jurisdiction in which the customer resides and/or with whom the customer opened and maintains his/her trading account. Saxo News & Research does not contain (and should not be construed as containing) financial, investment, tax or trading advice or advice of any sort offered, recommended or endorsed by Saxo Bank Group and should not be construed as a record of our trading prices, or as an offer, incentive or solicitation for the subscription, sale or purchase in any financial instrument. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, would be considered as a marketing communication under relevant laws.
Please read our disclaimers:
- Notification on Non-Independent Investment Research (https://www.home.saxo/legal/niird/notification)
- Full disclaimer (https://www.home.saxo/en-gb/legal/disclaimer/saxo-disclaimer)